Envestnet Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $469K | Buy |
|
|||||
|
2025
Q1 | $427K | Sell |
|
|||||
|
2024
Q4 | $767K | Buy |
|
|||||
|
2024
Q3 | $815K | Buy |
|
|||||
|
2024
Q2 | $491K | Sell |
|
|||||
|
2024
Q1 | $458K | Sell |
|
|||||
|
2023
Q4 | $506K | Buy |
|
|||||
|
2023
Q3 | $477K | Buy |
|
|||||
|
2023
Q2 | $461K | Sell |
|
|||||
|
2023
Q1 | $955K | Buy |
|
|||||
|
2022
Q4 | $1.14M | Sell |
|
|||||
|
2022
Q3 | $1.27M | Buy |
|
|||||
|
2022
Q2 | $896K | Sell |
|
|||||
|
2022
Q1 | $1.07M | Buy |
|
|||||
|
2021
Q4 | $1.27M | Buy |
|
|||||
|
2021
Q3 | $1.32M | Buy |
|